Male breast cancer

Area of Science:

• Oncology
• Genetics
• Epidemiology

Background:

• Male breast cancer is a rare condition, with peak incidence around age 71.
• Familial cases are more commonly associated with BRCA2 mutations than BRCA1.
• Risk factors include hyperoestrogenisation (Klinefelter's, obesity, alcohol) and radiation exposure.

Purpose of the Study:

• To summarize the epidemiology, risk factors, presentation, and management of male breast cancer.
• To highlight the importance of early detection and appropriate treatment strategies.

Main Methods:

• Review of existing literature on male breast cancer.
• Analysis of risk factors, clinical presentation, pathology, and treatment outcomes.

Main Results:

• Common presentations include lumps or nipple inversion, often at advanced stages (III/IV).
• Most tumors are ductal, with 10% being ductal carcinoma in situ.
• Oestrogen-receptor-positive tumors (90%) respond well to tamoxifen and hormonal therapy.

Conclusions:

• Male breast cancer management parallels female breast cancer, with surgery, radiotherapy, and hormonal therapy as mainstays.
• Chemotherapy may benefit some patients, particularly for metastatic disease.
• Improved national support and information initiatives are needed for male breast cancer patients.